Sexual Health Studies
Women’s Health:
Postmenopausal Conditions and PEMF:
Efficacy and safety of a device that combines multipolar radio frequency with pulsed electromagnetic field for the treatment of Vulvovaginal Atrophy: a randomized, sham-controlled trial
https://academic.oup.com/jsm/article-abstract/21/3/203/7591138?redirectedFrom=fulltext Date: 2024.01
Nonablative, noncoagulative multipolar RF/PEMF therapy was safe, improved symptoms associated with VVA, and improved female sexual function while yielding high subject satisfaction.
Pulse Electromagnetic Field for Treating Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
https://pubmed.ncbi.nlm.nih.gov/35864717/. Date: 2022. 07
Postmenopausal osteoporosis is a chronic disease with high morbidity and economic burden. A meta-analysis of 19 studies (1303 patients) found that pulsed electromagnetic fields (PEMF) combined with conventional medications significantly increased bone mineral density (BMD) and relieved pain compared to conventional medications alone, with no significant difference in adverse events. PEMF can be considered a potentially effective complementary therapy for postmenopausal osteoporosis.
Men’s Health:
Erectile Dysfunction and PEMF
6 HZ PEMF Therapy Can Aid in Treating Erectile Dysfunction
https://resona.health/2023/12/08/6-hz-pemf-therapy-can-aid-in-treating-erectile-dysfunction/ Date: 2023. 12
PEMF therapy has shown promising results in aiding the treatment of erectile dysfunction. By targeting the root causes of ED, such as poor blood flow and inflammation, this therapy can help improve overall sexual function and performance.
Prostate volume, vascularity, and benign hyperplasia (cyst) and PEMF
Effect of Pulsed Electromagnetic Field Therapy on ProstateVolume and Vascularity in the Treatment of Benign Prostatic Hyperplasia: APilot Study in a Canine Model
https://www.physiopod.co.uk/assets/files/pros22829.pdf Date: 2014
At all times libido was conserved and semen collection was easily performed.
Prostatic Volume: A progressive reduction of prostatic volume was recorded from T0 to T3. Prostate volume decreased an average of 57% over the course of the study.
Semen Quality and Prostatic Fluid: Semen characteristics were conserved over the treatment period. At T0 versus T3 the mean total sperm count (106) was 438.4/ 43.6 versus 443.7/ 38.8
Testosterone: Testosterone levels were at physiological range throughout the study. Testosterone at T0 (634 193 ng/dl) and at T3 (638 196 ng/dl)
Testosterone and PEMF:
The therapeutic effect of a pulsed electromagnetic field on the reproductive patterns of male Wistar rats exposed to a 2.45-GHz microwave field
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148471/ Date: 2011.07
Conclusion: Electromagnetic fields are recognized as hazards that affect testicular function by generating reactive oxygen species and reduce the bioavailability of androgen to maturing spermatozoa. Thus, microwave exposure adversely affects male fertility, whereas pulsed electromagnetic field therapy is a non-invasive, simple technique that can be used as a scavenger agent to combat oxidative stress. Results suggest that a 2.45-GHz microwave exposure causes apoptosis during spermiogenesis or sperm maturation, and sperm caspase-3 activity seems to affect the physiology of reproduction… All of these studies reveal that oxidative stress is a major mechanism affecting health, and microwave fields cause chronic stress via ROS overproduction. Pulsed electromagnetic field therapy provides significant protection by controlling ROS production.Prostate volume, vascularity, and benign hyperplasia (cyst) and PEMF
Effect of Pulsed Electromagnetic Field Therapy on ProstateVolume and Vascularity in the Treatment of Benign Prostatic Hyperplasia: APilot Study in a Canine Model
https://www.physiopod.co.uk/assets/files/pros22829.pdf Date: 2014
At all times libido was conserved and semen collection was easily performed.
Prostatic Volume: A progressive reduction of prostatic volume was recorded from T0 to T3. Prostate volume decreased an average of 57% over the course of the study.
Semen Quality and Prostatic Fluid: Semen characteristics were conserved over the treatment period. At T0 versus T3 the mean total sperm count (106) was 438.4/ 43.6 versus 443.7/ 38.8
Testosterone: Testosterone levels were at physiological range throughout the study. Testosterone at T0 (634 193 ng/dl) and at T3 (638 196 ng/dl)